semaglutide and epilepsy Newer glucose‐lowering drugs reduce the risk of late‐onset seizure epilepsy: A meta‐analysis - Sindhu - 2024 - Epilepsia Open GLP-1 receptor agonists in people

GLP-1 pens, needles, and medical cooling packs are exempt from TSA liquid limits because theyre medically necessary

Method: Often injected subcutaneously near the injury site

This was performed using a coupled online system consisting of both the Bruker trapped ion mobility time of flight mass spectrometer (Bruker Scientific, Billerica, MA), and the Evosep One liquid chromatography platform (Evosep, Odense, Denmark)

The Semaglutide Effects on CV Outcomes in Patients with Obesity or Overweight (SELECT) trial found a statistically significant reduction in the rate of all-cause mortality among patients receiving semaglutide compared to placebo recipients